How GLP-1 medicines affect stomach and bowel movement
Part of Hormones & metabolism clinical trials.
This study will look at how medicines like Ozempic, Wegovy, and Mounjaro affect how well the stomach and intestines move food through the body. It might help find out why these medicines cause digestive problems for some people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are starting a GLP-1 medicine like Ozempic, Wegovy, or Mounjaro, OR you stopped taking one of these more than 3 months ago.
- You have type 2 diabetes, and your blood sugar is fairly stable (an A1C test of 9% or lower within the last 6 months).
- Your thyroid hormone test (TSH) was normal within the last 6 months.
- You have not had surgery on your stomach or intestines, and you do not have a history of a blocked bowel or narrowing in your intestines.
- You have not taken certain medicines (like opioid painkillers, marijuana, anticholinergics, or pro-motility drugs) for at least 1 month, and you have not taken antibiotics in the past 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to see how GLP-1 RA medications (like Ozempic) affect the stomach in people with type 2 diabetes and obesity. It may help doctors better understand how these medicines work.
This study looks at how a newly started GLP-1 medicine (commonly used for weight loss or diabetes) changes the amount of food left in your stomach and how fast it empties. The goal is to understand these effects better, which may help improve safety and dosing.
This study tests whether a special bowel preparation plan works better for people taking GLP-1 or GIP medications (like Ozempic, Mounjaro) before a colonoscopy. It aims to improve the quality of the bowel cleaning so doctors can see the colon more clearly.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This trial tests whether taking a multivitamin and a probiotic together can improve gut health for people who are currently taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if these supplements help with digestive issues that can come with these medications.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.